99mTc-fanolesomab Palatin Technologies

Charito Love, Christopher J. Palestro

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.

Original languageEnglish (US)
Pages (from-to)1079-1085
Number of pages7
JournalIDrugs
Volume6
Issue number11
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Appendicitis
Osteomyelitis
Technology
Infection
monoclonal antibody anti-SSEA-1

ASJC Scopus subject areas

  • Pharmacology

Cite this

Love, C., & Palestro, C. J. (2003). 99mTc-fanolesomab Palatin Technologies. IDrugs, 6(11), 1079-1085.

99mTc-fanolesomab Palatin Technologies. / Love, Charito; Palestro, Christopher J.

In: IDrugs, Vol. 6, No. 11, 11.2003, p. 1079-1085.

Research output: Contribution to journalArticle

Love, C & Palestro, CJ 2003, '99mTc-fanolesomab Palatin Technologies', IDrugs, vol. 6, no. 11, pp. 1079-1085.
Love C, Palestro CJ. 99mTc-fanolesomab Palatin Technologies. IDrugs. 2003 Nov;6(11):1079-1085.
Love, Charito ; Palestro, Christopher J. / 99mTc-fanolesomab Palatin Technologies. In: IDrugs. 2003 ; Vol. 6, No. 11. pp. 1079-1085.
@article{acf0ed1b55b34a39ab5aa67dc87685a4,
title = "99mTc-fanolesomab Palatin Technologies",
abstract = "99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.",
author = "Charito Love and Palestro, {Christopher J.}",
year = "2003",
month = "11",
language = "English (US)",
volume = "6",
pages = "1079--1085",
journal = "IDrugs : the investigational drugs journal",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "11",

}

TY - JOUR

T1 - 99mTc-fanolesomab Palatin Technologies

AU - Love, Charito

AU - Palestro, Christopher J.

PY - 2003/11

Y1 - 2003/11

N2 - 99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.

AB - 99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.

UR - http://www.scopus.com/inward/record.url?scp=0344099030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344099030&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 1079

EP - 1085

JO - IDrugs : the investigational drugs journal

JF - IDrugs : the investigational drugs journal

SN - 1369-7056

IS - 11

ER -